Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Tanaya Bhowmick"'
Autor:
Jianye Sui, Zhongtian Lin, Shahriar Azizpour, Fei Chen, Sunanda Gaur, Kelly Keene, Farzad Soleimani, Tanaya Bhowmick, Zubaid Rafique, Mehdi Javanmard
Publikováno v:
PLoS ONE, Vol 19, Iss 1 (2024)
Externí odkaz:
https://doaj.org/article/353576fbe90c4edcbe84a00219e088b6
Publikováno v:
Engineering Proceedings, Vol 56, Iss 1, p 270 (2023)
The influence of riverine physicochemical factors on the overall physiological status and growth of river biofilms was established in a field-data-based model. Two sampling stations were located in the intermediate and downstream watershed areas of t
Externí odkaz:
https://doaj.org/article/b88f3405f91246ddb75c8378457409d8
Publikováno v:
Antimicrobial Stewardship & Healthcare Epidemiology, Vol 3 (2023)
Externí odkaz:
https://doaj.org/article/19beb968932f4230bf66bb602421b946
Autor:
Sana M. Mohayya, Mohammad Arsalan, Navaneeth Narayanan, Purvi Patel, Christin G. Hong, Thomas J. Kirn, Pinki J. Bhatt, Tanaya Bhowmick
Publikováno v:
Antimicrobial Stewardship & Healthcare Epidemiology, Vol 3 (2023)
Abstract Objective: Rapid diagnostic tests (RDTs) are increasingly being implemented as antimicrobial stewardship tools to facilitate antibiotic modification and reduce complications related to their overutilization. We measured the clinical impact
Externí odkaz:
https://doaj.org/article/385e679a9c694c379cfacd79b79edb28
Autor:
Deepali Dixit, PharmD, BCPS, BCCCP, FCCM, Polly Jen, PharmD, BCPS, BCIDP, AAHIVP, Tyler D. Maxwell, BS, PharmD, Steven Smoke, PharmD, BCPS, BCIDP, James Andrew McCracken, PharmD, Maria Cardinale-King, PharmD, BCCCP, Aditi Haribhakti, PharmD Candidate, Purvi Patel, MD, Eris Cani, BS, PharmD, BCIDP, BCPS, Seohyun (Claudia) Choi, PharmD, BCCCP, Sugeet Jagpal, MD, Tilly Varughese, MD, Luis L. Tatem, MD, Tanaya Bhowmick, MD
Publikováno v:
Critical Care Explorations, Vol 4, Iss 9, p e0762 (2022)
IMPORTANCE:. COVID-19 can cause serious illness requiring multimodal treatment and is associated with secondary infections. Studies have suggested an increased risk of fungal infections, including candidemia following severe COVID-19 though understan
Externí odkaz:
https://doaj.org/article/f65c9dabcfe04d79bc7011b82a081de8
Autor:
Tanaya Bhowmick, Melvin P. Weinstein
Publikováno v:
Infectious Diseases and Therapy, Vol 9, Iss 4, Pp 757-767 (2020)
Plain Language Summary Meropenem-vaborbactam is a new combination antibiotic that was designed specifically for efficacy against bacteria that produce the Klebsiella pneumoniae carbapenemase (KPC) enzyme, which enables resistance to beta-lactam antib
Externí odkaz:
https://doaj.org/article/0eb7212febee4d618d1845bd0336f16f
Autor:
Richard G. Wunderink, Evangelos J. Giamarellos-Bourboulis, Galia Rahav, Amy J. Mathers, Matteo Bassetti, Jose Vazquez, Oliver A. Cornely, Joseph Solomkin, Tanaya Bhowmick, Jihad Bishara, George L. Daikos, Tim Felton, Maria Jose Lopez Furst, Eun Jeong Kwak, Francesco Menichetti, Ilana Oren, Elizabeth L. Alexander, David Griffith, Olga Lomovskaya, Jeffery Loutit, Shu Zhang, Michael N. Dudley, Keith S. Kaye
Publikováno v:
Infectious Diseases and Therapy, Vol 7, Iss 4, Pp 439-455 (2018)
Abstract Introduction Treatment options for carbapenem-resistant Enterobacteriaceae (CRE) infections are limited and CRE infections remain associated with high clinical failure and mortality rates, particularly in vulnerable patient populations. A Ph
Externí odkaz:
https://doaj.org/article/106733a022be48b9ab7ef1601be3b1a5
Autor:
Sana M. Mohayya, Navaneeth Narayanan, Daniel Cimilluca, Alexander Malanowski, Parth Vaidya, Tanaya Bhowmick
Publikováno v:
Antibiotics, Vol 10, Iss 9, p 1078 (2021)
To minimize complications associated with over-utilization of antibiotics, many antimicrobial stewardship programs have incorporated an antibiotic time out (ATO); however, limited data are available to support its effectiveness. This was a single-cen
Externí odkaz:
https://doaj.org/article/76ad0c0fc78b46d99316e7f7b0086d2a
Autor:
Navaneeth Narayanan, Rena Rai, Parth Vaidya, Avani Desai, Tanaya Bhowmick, Melvin P. Weinstein
Publikováno v:
Therapeutic Advances in Infectious Disease, Vol 6 (2019)
Vancomycin-resistant enterococcal bacteremia (VRE-B) is a common nosocomial infection associated with significant morbidity and mortality. Daptomycin and linezolid are primary treatment options although definitive clinical data to assess comparative
Externí odkaz:
https://doaj.org/article/d76eb815d8104f048ffa366b3d56498d
Autor:
Michael J, Satlin, Liang, Chen, Angela, Gomez-Simmonds, Jamie, Marino, Gregory, Weston, Tanaya, Bhowmick, Susan K, Seo, Steven J, Sperber, Angela C, Kim, Brandon, Eilertson, Sierra, Derti, Stephen G, Jenkins, Michael H, Levi, Melvin P, Weinstein, Yi-Wei, Tang, Tao, Hong, Stefan, Juretschko, Katherine L, Hoffman, Thomas J, Walsh, Lars F, Westblade, Anne-Catrin, Uhlemann, Barry N, Kreiswirth
Publikováno v:
Clinical Infectious Diseases. 75:2066-2075
Background Patients with bacteremia due to carbapenem-resistant Enterobacterales (CRE) experience delays until appropriate therapy and high mortality rates. Rapid molecular diagnostics for carbapenemases and new β-lactam/β-lactamase inhibitors may
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a47b676f8c8bc043ee92f70ca1820802
https://doi.org/10.1093/cid/ciac354
https://doi.org/10.1093/cid/ciac354